Q98529932
committee directives from 2012
Press Enter · cited answer in seconds
0 sources
Q98529932
Summary
Q98529932 is a committee directives[1].
Key Facts
- Q98529932 is in the country of Sweden[2].
- Q98529932's instance of is recorded as committee directives[3].
- Q98529932's part of the series is recorded as committee directives from 2012[4].
- Q98529932's language of work or name is recorded as Swedish[5].
- Q98529932 was released on +2012-06-14T00:00:00Z[6].
- Q98529932's main subject is medication[7].
- Q98529932's work available at URL is recorded as http://data.riksdagen.se/dokument/H0B166.html[8].
- Q98529932's work available at URL is recorded as http://data.riksdagen.se/dokumentstatus/H0B166[9].
- Q98529932's applies to jurisdiction is recorded as Sweden[10].
- Q98529932's legal citation of this text is recorded as dir. 2012:66[11].
- Q98529932's title is recorded as Tilläggsdirektiv till Utredningen om vissa frågor om prissättning, tillgänglighet och marknadsförutsättningar inom läkemedels- och apoteksområdet (S 2011:07)[12].
- Q98529932's cites work is recorded as Q98530073[13].
- Q98529932's cites work is recorded as Q98530046[14].
- Q98529932's maintained by WikiProject is recorded as Project Riksdagen's documents[15].
- Q98529932's copyright status is recorded as public domain[16].
Body
Definition and Type
Q98529932's instance of is recorded as committee directives[3].